Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
Upside for Insmed after Brinsupri’s first-in-class sales beat
The first-in-class inflammatory drug beat sales estimates by 150% in its first full quarter, fueling fresh confidence in its blockbuster potential.
Angus Liu
Jan 9, 2026 10:40am
Biopharma industry gathers momentum in Q3
Nov 14, 2025 9:28am
Bayer stays positive on newer meds as pharma sales stagnate
Nov 12, 2025 11:46am
J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T
Nov 12, 2025 11:36am
AZ CEO: 'We can absorb the impact' of US drug pricing deal
Nov 6, 2025 10:40am
Supernus confronts Onapgo supply constraint early into launch
Nov 5, 2025 4:20pm
